Anteris Technologies Global Corp.

NASDAQ:AVR

Medical - Devices

Healthcare
$5.21 -0.16%

-$0.02 today

Market cap
$507.94M
Beta
0.73
P/E (TTM)
-2.3
EPS (TTM)
-$4.04
52W Low $2.85High $10.14

Volume 1.24M

Average 1.18M

AVR Weighted Avg Shares

Average number of basic shares outstanding during the period, used to calculate basic EPS.

Anteris Technologies Global Corp.NASDAQ: AVR

Weighted Avg Shares · Q1 FY2026 · quarter ended Mar 2026

Weighted avg shares growth accelerates

Q1 FY2026 weighted avg shares of 23.58M shares rose 0.0% year over year, ahead of the -20.8% change in trailing-twelve-month weighted avg shares. Sequentially, it rose 0.0% from the prior quarter. Over 3 fiscal years it compounded at -13.1% a year.

Context

  • Weighted avg shares increased in 1 of the last 3 fiscal years.

What to watch

Whether quarterly growth of +0.0% holds above the trailing-twelve-month pace of -20.8%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
23.58M+0.0% QoQ
Last fiscal yearDec 2025
23.58M+16.4% YoY
LTMMar 2026
23.58M-20.8% YoY
Weighted Avg Shares past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+0.0%——
1 year+16.4%——
3-year CAGR-13.1%——
5-year CAGR——
10-year CAGR——

Weighted Avg Shares history

Shares · from the income statement

Latest · FY2025
23.58M USD
Year-over-year change
+16.4%
4-year CAGR
-10.0%

Weighted Avg Shares vs competitors

How AVR compares with its peers on the latest reported figures

  • AVR's LTM Mar 2026 weighted avg shares of 23.58M shares is the lowest of the 6 companies compared; the peer median is 580.18M shares.
  • Its year-over-year change of -20.8% is the lowest of 6, against a peer median of +0.4%.
  • Over three fiscal years its annual growth of -13.1% compares with a peer median of +0.6%.
AVR Competitors Peer median
Weighted Avg Shares for AVR and competitors
Company Period LTM YoY 3-year CAGR
BSXBoston Scientific CorporationLTM Jun 20261.48B +0.4%+1.1%
MDTMedtronic plcLTM Jul 20261.28B -0.1%-1.2%
EWEdwards Lifesciences CorporationLTM Jun 2026580.18M -1.7%-1.9%
LIVNLivaNova PLCLTM Sep 202654.83M +0.6%+0.6%
AORTArtivion, Inc.LTM Mar 202646.79M +11.6%+4.2%
AVRAnteris Technologies Global Corp.LTM Mar 202623.58M -20.8%-13.1%
Peer median (excluding AVR) 580.18M+0.4%+0.6%

Competitors are the stored peer set for AVR. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue5.83M3.2M2.73M2.7M1.91M
Cost of Revenue3.93M2.9M1.86M1.44M2.23M
Gross Profit1.91M298.38K876.8K1.27M(317K)
Gross Margin32.7%9.3%32.1%46.8%-16.6%
Research & Development9.99M17.59M31.02M51.45M69.12M
Selling, General & Admin9.14M15.21M17.05M024.46M
Operating Expenses18.77M31.41M49.02M79.64M93.58M
Depreciation & Amortization640.09K774.08K1.16M1.51M1.66M
EBITDA(15.5M)(29.14M)(45.54M)(74.38M)(92.49M)
EBITDA Margin-265.8%-910.5%-1665.1%-2751.7%-4834.9%
Operating Income(16.86M)(31.11M)(48.14M)(78.37M)(93.89M)
Operating Margin-289.2%-972.1%-1760.3%-2899.4%-4908.2%
Interest Income68.55K210.38K428.06K0709K
Interest Expense1.03M648.71K67.09K82K73K
Other Income / Expenses(310.48K)550.48K1.38M2.41M(331K)
Income Before Tax(17.17M)(30.56M)(46.76M)(75.97M)(94.23M)
Pre-Tax Margin-294.5%-954.9%-1709.9%-2810.5%-4925.5%
Income Tax Expense00000
Net Income(17.17M)(30.56M)(46.02M)(76.29M)(94.14M)
Net Margin-294.5%-954.9%-1682.8%-2822.5%-4921.3%
EPS (Basic)(0.48)(0.85)(1.28)(3.77)(4.00)
EPS (Diluted)(0.48)(0.85)(1.28)(3.77)(4.00)
Weighted Avg Shares35.94M35.94M35.94M20.25M23.58M
Weighted Avg Shares (Diluted)35.94M35.94M35.94M20.25M23.58M

Anteris Technologies Global Corp.

NASDAQ:AVR

Intrinsic Alpha fair value

Locked

Current Price

$5.21

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.